Melior Pharmaceuticals

Melior Pharmaceuticals is a mid-stage biopharmaceutical company developing a pipeline of de-risked therapies in areas of significant unmet need. Our primary clinical candidate areas are diabetes, NASH, Parkinson's disease, and sleep disorders. We leverage our affiliate Melior Discovery's proprietary drug repositioning technology to identify new targets and indications for candidates that have already undergone preclinical and/or clinical studies for other indications.